JP2020519656A5 - - Google Patents

Download PDF

Info

Publication number
JP2020519656A5
JP2020519656A5 JP2019562657A JP2019562657A JP2020519656A5 JP 2020519656 A5 JP2020519656 A5 JP 2020519656A5 JP 2019562657 A JP2019562657 A JP 2019562657A JP 2019562657 A JP2019562657 A JP 2019562657A JP 2020519656 A5 JP2020519656 A5 JP 2020519656A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
topical pharmaceutical
composition according
tazarotene
emulsion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019562657A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020519656A (ja
JP7410720B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/032359 external-priority patent/WO2018209262A1/en
Publication of JP2020519656A publication Critical patent/JP2020519656A/ja
Publication of JP2020519656A5 publication Critical patent/JP2020519656A5/ja
Application granted granted Critical
Publication of JP7410720B2 publication Critical patent/JP7410720B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019562657A 2017-05-12 2018-05-11 皮膚疾患を治療するための局所組成物および方法 Active JP7410720B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762505421P 2017-05-12 2017-05-12
US62/505,421 2017-05-12
PCT/US2018/032359 WO2018209262A1 (en) 2017-05-12 2018-05-11 Topical compositions and methods for treating skin diseases

Publications (3)

Publication Number Publication Date
JP2020519656A JP2020519656A (ja) 2020-07-02
JP2020519656A5 true JP2020519656A5 (enExample) 2021-07-26
JP7410720B2 JP7410720B2 (ja) 2024-01-10

Family

ID=62386996

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019562657A Active JP7410720B2 (ja) 2017-05-12 2018-05-11 皮膚疾患を治療するための局所組成物および方法

Country Status (8)

Country Link
US (1) US20180360752A1 (enExample)
EP (1) EP3621614B1 (enExample)
JP (1) JP7410720B2 (enExample)
BR (1) BR112019023817A8 (enExample)
CA (1) CA3063371A1 (enExample)
PL (1) PL3621614T3 (enExample)
RS (1) RS67211B1 (enExample)
WO (1) WO2018209262A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102643849B1 (ko) 2015-06-18 2024-03-07 밸리언트 파마슈티컬즈 노오쓰 아메리카 엘엘씨 건선을 치료하기 위한 코르티코스테로이드 및 레티노이드를 포함하는 국소 조성물
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases
US20260007646A1 (en) * 2022-09-16 2026-01-08 Bausch Health Ireland Limited Methods for treating acne and skin oiliness with tazarotene

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1210041C (zh) * 2003-09-29 2005-07-13 中国医学科学院皮肤病研究所 治疗痤疮的复方外用药物
KR102643849B1 (ko) * 2015-06-18 2024-03-07 밸리언트 파마슈티컬즈 노오쓰 아메리카 엘엘씨 건선을 치료하기 위한 코르티코스테로이드 및 레티노이드를 포함하는 국소 조성물

Similar Documents

Publication Publication Date Title
JP2016535781A5 (enExample)
MX2017014804A (es) Composiciones farmaceuticas topicas.
AU2017320876B2 (en) Methods and compositions for treating cutaneous fungal infections
JPH0222211A (ja) 老化皮膚を治療するための局所適用可能な製剤
JP2011521948A (ja) 皮膚の炎症および変色のための方法ならびに組成物
JP2018526325A5 (enExample)
EP4659740A3 (en) Kx2-391/kx-01 for use in the treatment of actinic keratosis
EA201300314A8 (ru) Композиции и лекарственное средство для лечения глазных болезней, устройство, содержащее композиции и лекарственное средство
WO2023141334A3 (en) Pharmaceutical compositions of mycophenolic acid and/or betamethasone for the treatment of ocular disorders
EP3125865B1 (en) Association of active ingredients for topical use in restructuring altered cutaneous barrier following to cutaneous diseases
EP2135622B1 (en) Compositions for providing an analgesic effect to the skin
HRP20211661T1 (hr) Igmezin, namijenjen upotrebi u liječenju alzheimerove bolesti
US20230293492A1 (en) Methods and compositions for treating cutaneous fungal infections
WO2015100348A8 (en) Keloid reduction using topical allantoin
RU2007117790A (ru) Кислые и буферные композиции для ухода за кожей, содержащие никотиномид и абсорбирующий агент
WO2013174725A3 (en) Cosmetic composition comprising the combination of a lipophilic salicylic acid derivative, an antiperspirant aluminium salt or complex and an amino acid-n,n-diacetic acid salt
WO2014047288A3 (en) Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
WO2013158318A1 (en) Formulations and methods for treatment of acne and inflammatory skin conditions
CL2018003268A1 (es) Ácidos carboxílicos para tratar/prevenir una enfermedad de la piel.
WO2014118527A1 (en) Topical composition comprising dantrolene and/or azumolene
RU2011121659A (ru) Депигментирующие местные композиции и их применение
US10438128B2 (en) Treatment of autoimmune and inflammatory diseases with the arsenic compounds AS2O3 and/or AS2O5 administered locally
MX2018013474A (es) Acidos carboxilicos para aplicacion en la primera infancia.
JP2026501004A (ja) マラセチア属酵母によって誘発される病態の治療において使用するためのアボカド不鹸化物
JP2011012004A (ja) 皮膚外用剤組成物